Form D — Alphina Therapeutics, Inc.
0001882991-26-000003 · filed Mar 16, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $10,000,000
- Reported amount sold
- $153,715
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Alphina Therapeutics, Inc.
- CIK
- 1882991
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 55 Church Street
New Haven, CT 06510 - Phone
- (650) 438-8738
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Nicholas J Galli · Executive OfficerNew Haven, CT Find on LinkedIn ↗
-
Ranjit Bindra · DirectorNew Haven, CT Find on LinkedIn ↗
-
Kevin Rakin · DirectorNew Haven, CT Find on LinkedIn ↗
-
Colleen Cuffaro · DirectorWestport, CT Find on LinkedIn ↗
-
Barbara Fox · Executive OfficerNew Haven, CT Find on LinkedIn ↗
-
Matthew Cohen · DirectorBala Cynwyd, PA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗